Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                        Aviation   Pharma   About Us   Feedback   Links

NOVARTIS SUED FOR 'UNSTOPPABLE ERECTION'

Man suffers 'unstoppable' erection, sues Novartis

BY OUR PHARMA CORRESPONDENT


 

June 10, 2007: A man from New York filed a lawsuit against Swiss drug giant Novartis AG alleging that a health drink made by the company gave him an erection that turned unstoppable and landed him in hospital.

Christopher Woods, 29, consumed a nutritional beverage, Boost Plus, that he had bought from a New York drug store. Next morning he woke up with an erection that wouldn’t go down. Then he rushed to a nearby hospital seeking help. The doctors advised him to go for a surgery.

Following their recommendation, Woods underwent surgery for a condition medically known as severe priapism. Surgeons implanted him with a Winter shunt. The shunt diverts blood flows from one area to another.

However, according to the lawsuit, Woods’ problems did not end there. He again required hospitals visits for different problems. He was hospitalised for penile artery embolization, a way of closing blood vessels. He alleged that subsequent procedures such as closing off some blood flow prevents engorgement. This lessens his chances for getting a normal erection.

So, unspecified damages are sought through the lawsuit that names Novartis Consumer Health Inc. as a defendant.

Novartis markets Boost Plus as a health drink enriched by vitamins in different flavours. Its advertising campaign describes Boost Plus as a great tasting, high calorie, nutritionally complete oral supplement for people who require extra energy and protein in a limited volume." But it mentions nowhere that it boosts one’s libido too!
 

BY OUR PHARMA CORRESPONDENT

 

 

Latest Stories in Pharma

 

Global travel of US lawyer with rare TB raises health concerns

DNA-discoverer has his genome mapped

China takes over world’s antibiotics, enzymes markets

Man suffers 'unstoppable' erection, sues Novartis

Torisel, the renal cell carcinoma drug, gets FDA approval

Nexavar extends life of liver cancer patients

Free HIV drug for Africa from Roche

China rejects US FDA’s warning on Chinese toothpaste

Kick the butt with Champix

Breast cancer predictions get better

 

Archive: 7 Jan 2007

Archive: 14 Sep, 2005

 

 

 

Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                        Aviation   Pharma   About Us   Feedback   Links

Latest updates    Contact Us - Feedback    About Us